A R Zander|K J Cockerill - JoVE Visualize

Showing results (91-100 of 196) with videos related to

Pageof 20

Sort By:

Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000

CD34 splice variant: an attractive marker for selection of gene-modified cellsB Fehse, A Richters, K Putimtseva-Scharf, et al.

Bone Marrow Transplantation|June 1, 2002

Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donorsN Kröger, H Renges, S Sonnenberg, et al.

British Journal of Haematology|September 12, 1998

Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patientsN Kröger, W Zeller, N Fehse, et al.

Annals of Internal Medicine|July 1, 1980

4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemiaS S Legha, M J Keating, A R Zander, et al.

Anticancer Research|January 1, 1997

Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experienceH T Hassan, C Krog, M Stockschläder, et al.

Transplantation|August 1, 1985

Immune recovery following allogeneic bone marrow transplantationA R Zander, J M Reuben, D Johnston, et al.

Journal of Hematotherapy & Stem Cell Research|March 29, 2001

Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cellsF Tögel, C Datta, A Badbaran, et al.

Bone Marrow Transplantation|January 1, 1995

Inhibition of CFU-C growth by VP-16 containing plasma samples obtained from patients after conditioning therapy for bone marrow transplantationW H Krüger, C Berger, K B Mross, et al.

British Journal of Cancer|November 20, 1998

Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitroR Jung, W Krüger, S Hosch, et al.

Journal of Cancer Research and Clinical Oncology|January 1, 1996

Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patientsW Krüger, C Krzizanowski, M Holweg, et al.

Pageof 20

Showing results (91-100 of 196) with videos related to

Sort By:

Pageof 20

Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000

CD34 splice variant: an attractive marker for selection of gene-modified cellsB Fehse, A Richters, K Putimtseva-Scharf, et al.

Bone Marrow Transplantation|June 1, 2002

Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donorsN Kröger, H Renges, S Sonnenberg, et al.

British Journal of Haematology|September 12, 1998

Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patientsN Kröger, W Zeller, N Fehse, et al.

Annals of Internal Medicine|July 1, 1980

4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemiaS S Legha, M J Keating, A R Zander, et al.

Anticancer Research|January 1, 1997

Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experienceH T Hassan, C Krog, M Stockschläder, et al.

Transplantation|August 1, 1985

Immune recovery following allogeneic bone marrow transplantationA R Zander, J M Reuben, D Johnston, et al.

Journal of Hematotherapy & Stem Cell Research|March 29, 2001

Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cellsF Tögel, C Datta, A Badbaran, et al.

Bone Marrow Transplantation|January 1, 1995

Inhibition of CFU-C growth by VP-16 containing plasma samples obtained from patients after conditioning therapy for bone marrow transplantationW H Krüger, C Berger, K B Mross, et al.

British Journal of Cancer|November 20, 1998

Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitroR Jung, W Krüger, S Hosch, et al.

Journal of Cancer Research and Clinical Oncology|January 1, 1996

Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patientsW Krüger, C Krzizanowski, M Holweg, et al.

Pageof 20